Pipradrol

Pipradrol is a stimulant drug of the piperidine class that was developed in the 1950s. It displays nootropic effects and is used medically for treatment of conditions such as narcolepsy and ADHD. It is also used recreationally for its euphoric effects.

History

Pipradrol was first synthesized in the 1940s and was marketed for medical use in the 1950s. It was used as a treatment for a variety of conditions, including chronic fatigue, depression, and narcolepsy. However, due to concerns about its potential for abuse, it was withdrawn from the market in many countries in the 1970s and 1980s.

Pharmacology

Pipradrol acts as a norepinephrine-dopamine reuptake inhibitor, increasing the levels of these neurotransmitters in the brain. This results in increased alertness, focus, and energy, making it useful for conditions such as ADHD and narcolepsy. However, it can also cause side effects such as insomnia, anxiety, and psychosis in high doses.

Legal status

Pipradrol is a controlled substance in many countries, including the United States, where it is classified as a Schedule II drug. It is also controlled in the United Kingdom under the Misuse of Drugs Act 1971.

See also

• Desoxypipradrol
• Methylphenidate
• Amphetamine

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia